pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·2h ago·1 min read
save

CDMO hiring struggles as demand for specialized talent outpaces supply

Aug 26, 2026·read at BioSpace ↗Neutral

Contract development and manufacturing organizations are finding it harder to fill positions, according to a search expert who tracks life-science talent. The surge in outsourcing has created a gap between the number of open roles and the pool of qualified candidates.

Dave Bowers, managing director at EPM Scientific, said the shortage is especially acute for highly specialized skills such as peptide process chemistry, which can take many years to master. He noted that higher salaries alone cannot create the expertise needed.

Industry data from Vision Lifesciences shows the global CDMO market grew to roughly $210 billion in 2025, up from $170 billion in 2022, driven by three structural forces that are expanding demand for outsourced manufacturing.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “CDMO hiring tough as demand for specialized talent outpaces supply”

read at BioSpace ↗
1,117 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING
topics
CRO/CDMO10Ophthalmology2Peptide Therapeutic2Drug Shortage

related stories

  • Jul 21Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesityBioSpace
  • Jul 20Samsung Bio to step into peptides in $1.8B buy for PolyPeptideEndpoints
  • Apr 27Opinion: I’m a fourth-year med student, but I only learned one historical example of medical racismSTAT
  • 19h agoCellares cuts jobs after losing pharma customerBioSpace
  • Jul 27STAT+: Pharma’s drug spending deflectionSTAT